Senior Software Engineer, GRAIL
Early cancer detection and research
Job no longer available
Early cancer detection and research
1001+ employees
Job no longer available
1001+ employees
Company mission
GRAIL's mission is to transform cancer care through early detection.
Role
Who you are
- Bachelor's or Master's degree in Computer Science, Mathematics, Electrical Engineering, Bioinformatics or similar technical field
- 5+ years of work experience designing, developing, testing and maintaining software
- Experienced in a general-purpose programming language such as Go, Python, Java, Javascript, etc, but understand these are tools to solve problems
- Experience developing and deploying services to platforms such as AWS, GCP, or Microsoft Azure
- Passionate about software engineering, as well as software engineering teams
- Excellent logical reasoning and analytical skills, with a preference for simple solutions
- Strong written and verbal communicator and can adapt your communication style and the level of detail to your audience
What the job involves
- Use your experience developing distributed systems to build software that supports the research efforts of GRAIL and its partners
- Collaborate with a multi-functional team (UK/US) to overcome real-world problems that sometimes can’t be solved with software alone
- Build and operate the platform and tooling that powers the team
- Take ownership for the systems built by the team by participating in an on-call rota
Salary benchmarks
Our take
Detecting cancer early matters a lot. Survival rates are much higher when cancer is diagnosed in earlier stages. However, early screening only exists for a limited number of cancer types and the majority of cancer diagnosis are made later, when survival rates are much lower.
GRAIL is on a mission to improve cancer detection and save lives. By bringing together experts in bioinformatics, clinical science and deep learning, the company is building models from tumour genome sequencing data to provide actionable insights into how multiple types of cancers could be detected early using blood tests.
The development of these blood tests is supported by population-scale clinical studies. GRAIL is building an atlas characterising the levels of 'cell-free nucleic acids' (a key indicator of cancers) in thousands of individuals with and without cancer to help validate their early-stage tests. These will be some of the largest cancer-related studies ever to date. The company has also developed Garelli - a new blood test that has the ability to detect more than 50 types of cancer through a single blood draw, now becoming available on health insurance plans such as Curative Insurance.
Freddie
Company Specialist at Welcome to the Jungle
Insights
11% employee growth in 12 months
Company
Funding (last 2 of 5 rounds)
May 2020
$390m
SERIES D
Dec 2019
$125m
SERIES D
Total funding: $1.8bn
Company benefits
- Outstanding People - Join a team of passionate and dedicated professionals, committed to collaboration, education, and proactive problem-solving.
- Strong Compensation - We offer competitive salaries and savings plans to provide for long-term financial planning.
- Complete Health Coverage - Take advantage of comprehensive health coverage, with medical, dental and vision, to keep you and your family healthy.
- Work-Life Balance - Make everyday life more manageable with flexible time off – we trust you to do great work and take time for yourself.
Company HQ
Menlo Park, CA
Leadership
Bob Ragusa
(CEO, not founder)BSE and MSE from Carnegie Mellon and MBA from University of Connecticut. Over 3 years as a EVP at Accuray and 7 years as COO at Illumina. Currently a Board member at Twist Bioscience.
Share this job